1719 Epizód

  1. Small Molecule PCSK9 Inhibitor for Hypercholesterolemia | JACC | ACC.25

    Közzétéve: 2025. 04. 01.

  2. Effect of ANGPTL3 Inhibition With Solbinsiran in Preclinical and Early Human Studies | JACC | ACC.25

    Közzétéve: 2025. 04. 01.

  3. Early Intra-Aortic Balloon Support for Heart Failure-Related Cardiogenic Shock | JACC | ACC.25

    Közzétéve: 2025. 04. 01.

  4. Individual Variation in Tirzepatide Response | JACC | ACC.25

    Közzétéve: 2025. 04. 01.

  5. Survival After Sudden Cardiac Arrest in Athletes | JACC | ACC.25

    Közzétéve: 2025. 04. 01.

  6. Self-Expanding Valve Outcomes at 5 Years Compared to Surgery | JACC | ACC.25

    Közzétéve: 2025. 04. 01.

  7. Gold Cards & Hidden Triggers: A New Look at Afib | JACC Baran

    Közzétéve: 2025. 04. 01.

  8. Nonlinear Relation between Cardiac Mortality and Excess Temperature in Heatwaves: Exposure Response in 2.39 Million Patients | JACC

    Közzétéve: 2025. 03. 31.

  9. New Threshold for Defining Mild Aortic Stenosis Derived from Velocity-Encoded MRI in 60,000 Individuals | JACC

    Közzétéve: 2025. 03. 31.

  10. The Cardiovascular Care of the Pediatric Athlete | JACC

    Közzétéve: 2025. 03. 31.

  11. April 8, 2025 Issue Summary | JACC

    Közzétéve: 2025. 03. 31.

  12. Impact of Transcather or Surgical Aortic Valve Performance on 5-Year Outcomes in Patients at ≥Intermediate Risk | JACC

    Közzétéve: 2025. 03. 31.

  13. Incident Atrial Fibrillation in FINE-HEART | JACC | ACC.25

    Közzétéve: 2025. 03. 27.

  14. Use of Cardiac Rehab in Older Patients with MI Complicated by Cardiogenic Shock | JACC | ACC.25

    Közzétéve: 2025. 03. 25.

  15. Effect of plozasiran on lipoprotein particles by NMR | JACC | ACC.25

    Közzétéve: 2025. 03. 25.

  16. Exploring High-Gradient Aortic Stenosis | JACC Baran

    Közzétéve: 2025. 03. 25.

  17. Vutrisiran Efficacy by Baseline ATTR-CM Severity | JACC | ACC.25

    Közzétéve: 2025. 03. 24.

  18. Invasive versus Conservative Management of Patients with Chronic Total Occlusion: Results From the ISCHEMIA Trial | JACC

    Közzétéve: 2025. 03. 24.

  19. Elevated remnant cholesterol contributes to the risk of peripheral artery disease: a Mendelian randomization study | JACC

    Közzétéve: 2025. 03. 24.

  20. Guideline-Directed Medical Therapy and Outcomes in the ISCHEMIA Trial | JACC

    Közzétéve: 2025. 03. 24.

4 / 86

Each week, Valentin Fuster, MD, PhD, MACC, records free podcasts highlighting journal findings. To keep clinicians updated on the most important science emerging in clinical and translational cardiology, Dr. Fuster provides an overview of the weekly edition from the Journal of the American College of Cardiology (JACC), as well as a short summary of each manuscript. Encompassing JACC and nine cardiovascular specialty journals, the JACC family of journals rank among the top cardiovascular peer-reviewed journals in the world for scientific impact.

Visit the podcast's native language site